Data as of Nov 21
| +0.04 / +0.54%|
The 1 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 34.00, with a high estimate of 34.00 and a low estimate of 34.00. The median estimate represents a +357.60% increase from the last price of 7.43.
The current consensus among 1 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.